Literature DB >> 17287717

Trends in the epidemiology of invasive fungal infections.

David W Warnock1.   

Abstract

Invasive fungal infections have increased in importance, largely because of the increasing size of the population at risk. Candida species remain the fourth most important cause of hospital-acquired bloodstream infections. Infections with Candida species other than C. albicans appear to have become more common, but significant geographic variation has been reported. Invasive aspergillosis and other mould infections are a leading cause of infection-related death in hematopoietic stem cell transplant recipients. Although Aspergillus fumigatus remains the most frequent cause of infection, A. terreus has emerged as an important pathogen, at least among certain populations. Despite marked reductions in the rates of AIDS-associated fungal infections, such as cryptococcosis, in the United States and other developed countries, the burden of these diseases in developing countries is large and increasing. Enhanced surveillance and reporting will be critical to improve our understanding of the importance of invasive fungal infections, to enable prioritization of research and prevention efforts, and to evaluate prevention strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17287717     DOI: 10.3314/jjmm.48.1

Source DB:  PubMed          Journal:  Nihon Ishinkin Gakkai Zasshi        ISSN: 0916-4804


  48 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

Review 3.  Safety of micafungin in infants: insights into optimal dosing.

Authors:  Simon Ascher; Phillip Brian Smith; Daniel K Benjamin
Journal:  Expert Opin Drug Saf       Date:  2011-01-13       Impact factor: 4.250

Review 4.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

5.  Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis.

Authors:  Manisha Shukla; Soma Rohatgi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 6.  Clinically relevant drug-drug interactions between antiretrovirals and antifungals.

Authors:  Ramya Krishna Vadlapatla; Mitesh Patel; Durga K Paturi; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-02-12       Impact factor: 4.481

7.  Evaluation of novel broad-range real-time PCR assay for rapid detection of human pathogenic fungi in various clinical specimens.

Authors:  Tanja Vollmer; Melanie Störmer; Knut Kleesiek; Jens Dreier
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

Review 8.  Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.

Authors:  Emily Zoller; Connie Valente; Kyle Baker; Michael E Klepser
Journal:  Drug Des Devel Ther       Date:  2010-11-04       Impact factor: 4.162

9.  Performance of optimized McRAPD in identification of 9 yeast species frequently isolated from patient samples: potential for automation.

Authors:  Jitka Trtkova; Petr Pavlicek; Lenka Ruskova; Petr Hamal; Dagmar Koukalova; Vladislav Raclavsky
Journal:  BMC Microbiol       Date:  2009-11-10       Impact factor: 3.605

10.  Global screening of potential Candida albicans biofilm-related transcription factors via network comparison.

Authors:  Yu-Chao Wang; Chung-Yu Lan; Wen-Ping Hsieh; Luis A Murillo; Nina Agabian; Bor-Sen Chen
Journal:  BMC Bioinformatics       Date:  2010-01-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.